Top 33 medical and healthcare startups in Los Angeles

May 03, 2026
|
1
Nervonik
Funding: $65.5M
Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system.
2
Acelyrin
Funding: $558M
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing inflammatory-disease-focused therapies.
3
HealthCheck Diagnostics
Funding: $368.4M
HealthCheck Diagnostics seeks to reduce mortality in CAD and atherosclerosis patients with breakthrough biomarker testing that reveals cardiovascular disease and likely heart attacks through a non-invasive procedure.
4
Function Health
Funding: $354M
Function Health is a continuous health checkup service. For $365/year, users schedule and undergo over 100 lab tests (including advanced add-ons like MRIs), receive detailed clinical health assessments and early detection of serious illnesses. No insurance needed. Diagnostics are performed by human experts using a medical artificial intelligence model. The company also offers its users a chatbot (an AI health manager) that can answer questions based on their health data and use previous lab results, doctor notes, and imaging to provide personalized recommendations. The platform is HIPAA-compliant, fully encrypts user data, and never sells personal information.
5
Kite Pharma
Funding: $335.4M
Kite Pharma develops and produces immune-based cell therapies to treat cancer. Each cell therapy developed by the company is individually tailored to each patient and one-time injected. The CAR T-cell therapy manufacturing process involves collecting the patient's white blood cells, isolating and activating the T-cells, modifying the T-cells with a chimeric antigen receptor gene, culturing and expanding the T-cells and administering the modified T-cells to the same patient. Kite has a state-of-the-art manufacturing facility with full production cycle and global logistics network. The company's portfolio includes two drugs for the treatment of blood diseases, specifically diffuse large B-cell lymphoma, mantle cell lymphoma and acute lymphoblastic leukemia. The company's pipeline includes clinical trials for the treatment of lymphoma, myeloma and leukemia. Acquired by Gilead Sciences
6
CenterWell
Funding: $171.1M
Heal is startup offering house calls with primary care doctors, along with video appointments
7
Pelage Pharmaceuticals
Funding: $150M
Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss.
8
Octant Bio
Funding: $115M
Octant Bio is a developer of synthetic technology used to improve health and treat disease.
9
Regard
Funding: $81.4M
Regard uses AI to automatically diagnose patients and generate accurate notes for doctors to improve patient care and reduce burnout.
10
VoxelCloud
Funding: $78.5M
VoxelCloud provides automated medical image analysis services and diagnosis assistance based on AI and cloud computing technologies. VoxelCloud develops computer-aided detection systems for detecting and diagnosing various diseases ranging from cardiovascular and lung diseases to eye diseases. Our solutions are based on the state-of-the-art computer vision, deep learning and artificial intelligence technology.
11
PictorLabs
Funding: $48.8M
PictorLabs is developing a virtual staining platform for histopathology, or the microscopic exam of tissue
12
EyeNuk
Funding: $47.4M
Eyenuk, Inc. is a global digital health company and leader in real-world AI eye screening for autonomous disease detection
13
Wellth
Funding: $39.1M
Wellth provides an app that rewards patients for completing health behaviors like taking medications or monitoring blood pressure.
14
Moving Analytics
Funding: $31.6M
Moving Analytics is a provider of turnkey and home-based post-acute care management solutions for cardiopulmonary disease.
15
SpectrumAi
Funding: $29M
SpectrumAi is modernizing and democratizing access to high-quality autism treatment.
16
Tripp
Funding: $26.3M
The award-winning digital psychedelic wellness platform that uses the power of virtual and augmented reality to change the way you feel.
17
NeuroSigma
Funding: $18.4M
NeuroSigma is a life sciences company focused on bioelectronics products and commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), Lennox Gastaut syndrome (LGS) and traumatic brain injury (TBI).
18
Mahmee
Funding: $14M
Mahmee is an integrated care delivery platform for maternal and infant health.
19
Surgical Theater
Funding: $11.1M
Surgical Theater develops Medical Virtual Reality platform for neurosurgical pre-operative planning and rehearsal.
20
Gento
Funding: $7.8M
Gento is transforming the way in-home care is delivered by directly connecting providers, clinicians, and patients.
21
HotSpot Therapeutics
Funding: $5.5M
Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new ways. Unlike conventional drug discovery, which focuses on targeting the active sites of proteins, HotSpot has developed a technology platform to uncover nature’s privileged regulatory hotspots – pockets remote from the active site that are critical to protein function.
22
Embodied Labs
Funding: $4.3M
Embodied Labs is an immersive training platform that improves outcomes in training, awareness, and family and caregiver support.
23
Options MD
Funding: $4.2M
Options MD provides personalized care for people suffering from severe and treatment-resistant mental illnesses.
24
GigXR
Funding: $3.5M
GIGXR is a SaaS startup that uses mixed reality to drive training outcomes in healthcare, helping to save lives and costs globally.
25
VMocion
Funding: $3M
VMocion uses Virtual Reality to reduce motion sickness in an extended reality environment by stimulating the inner ear's vestibular system.
26
LIT Method
LIT Method is a combination of personal training, physical therapy, and injury prevention — and its signature LIT Strength Machine is an all-in-one water rower, Pilates reformer, and resistance band training system offering more than 500+ low impact exercises including strength, cardio, Pilates, rowing, and recovery.
27
Forcyte Biotechnologies
Funding: $1.5M
Forcyte Biotechnologies provides drug-makers and researchers direct access to cellular force generation at the single-cell level – a cellular behavior that was previously inaccessible in an automated way.
28
Symphony Bio
Funding: $400K
Symphony Biosciences is orchestrating the immune response against cancer using innovative biomaterials.
29
Aiva Health
Funding: $250K
Aiva is a patient voice assistant, which specializes in hands-free communication between patients and caregivers.
30
Ejenta
Funding: $156K
Ejenta is an intelligent personal assistant platform focused on several industry verticals, including space, government, and healthcare. It has an exclusive license agreement with NASA for an intelligent agent platform called Brahms.
31
Frontive Health
Frontive Health develops smart, personal health assistant combining voice and AI to make it easier for patients to manage complex care situations.
32
Yosko
Yosko is a mobile application that interfaces with the Electronic Health Record (EHR) systems to provide on-the-go access to patient records, streamlined hand-offs and improved staff communication.
33
BioAstra
BioAstra intends to genetically enhance astronauts for Mars missions. The company aims to develop and test potential countermeasures against DNA-damaging cosmic rays emitted by exploding supernovae, which could bombard crew capsules flying outside Earth's protective magnetic shield. For this purpose the company is preparing three space missions - to low Earth orbit, around the Moon and then during a flight around Mars. To accurately track the genetic changes induced during these three missions, BioAstra will use exact DNA twins - one half of a pair of identical human twins - on each mission, while a "control" sibling will remain on Earth, out of reach of dangerous cosmic and solar radiation.
  See also:
Editor: Jason Kwon
Jason Kwon is a senior editor for MedicalStartups. He has previously covered the pharmaceutical and medical research industries for FDAnews and worked as a head of marketing for medical startup Sonic Therapeutics. Before that, he co-founded a startup consulting business for emerging entrepreneurial hubs in Asia. Jason graduated from St. Bonaventure University’s journalism school. In his free time, Jason enjoys yoga, watching movie trailers, traveling to places where he can't get cell service. You can contact Jason at jaskwon(at)medicalstartups(dot)com